The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human CEB-01: Novel loco-regional SN-38 release membrane to prevent local recurrence in retroperitoneal sarcomas.
 
José Antonio González-Lopez
No Relationships to Disclose
 
Ana Sebio
Consulting or Advisory Role - Boehringer Ingelheim; Deciphera; GlaxoSmithKline; PharmaMar
Travel, Accommodations, Expenses - CEBIOTEX; Deciphera; Merck; PharmaMar; Roche
 
Nadia Hindi
Honoraria - PharmaMar; Tecnofarma
Consulting or Advisory Role - GlaxoSmithKline; PharmaMar
Research Funding - Adaptimmune (Inst); Ayala Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb/Pfizer (Inst); CEBIOTEX (Inst); Deciphera (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immix BioPharma (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Philogen (Inst); PTC Therapeutics (Inst); Rain Therapeutics (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Montiel Jimenez
No Relationships to Disclose
 
Pedro Villarejo-Campos
No Relationships to Disclose
 
Javier Martin-Broto
No Relationships to Disclose
 
Robert Díaz-Beveridge
No Relationships to Disclose
 
Juan Francisco Orbis Castellanos
No Relationships to Disclose
 
Rafael López Andújar
No Relationships to Disclose
 
Rosa Álvarez Álvarez
Consulting or Advisory Role - Boehringer Ingelheim; GlaxoSmithKline; Novartis; PharmaMar; Roche/Genentech
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); CEBIOTEX (Inst); Janssen Oncology; MSD Oncology (Inst); Novartis; PharmaMar (Inst); Rain Therapeutics; Roche/Genentech; Takeda (Inst)
Travel, Accommodations, Expenses - MSD Oncology; PharmaMar; Roche
 
José Manuel Asencio
No Relationships to Disclose
 
Cesar Serrano
Honoraria - Deciphera; PharmaMar; Roche
Consulting or Advisory Role - Blueprint Medicines; Cogent Biosciences; Deciphera; IDRX; Immunicum; NewBay Pharma
Research Funding - IDRX (Inst); Karyopharm Therapeutics (Inst)
Travel, Accommodations, Expenses - Bayer; Gilead Sciences; Pfizer; PharmaMar
 
Nivardo Rodríguez Conde
No Relationships to Disclose
 
Sandra Castro Boix
No Relationships to Disclose
 
Lucas Krauel Gimenez-Salinas
No Relationships to Disclose
 
José Antonio Tornero García
No Relationships to Disclose
 
Antonio Perez Campos
No Relationships to Disclose
 
Ester Lopera
No Relationships to Disclose
 
Joan Bertran
No Relationships to Disclose
 
Antonio López Pousa
No Relationships to Disclose